Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Sexually Transmitted Infections01:26

Sexually Transmitted Infections

422
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
422
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

47.0K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
47.0K
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

2.8K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
2.8K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

360
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
360
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

182
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
182
Standard Precaution01:26

Standard Precaution

2.2K
Standard precautions are the minimum infection control safeguards used while caring for all patients, irrespective of their disease condition. They help prevent the spread of common infectious microorganisms to healthcare workers, patients, and visitors in all healthcare settings.
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
2.2K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

GIDISdb: a gene expression database for exploring human immune responses in infectious diseases.

Database : the journal of biological databases and curation·2026
Same author

Synergistic regulation of iron cycle and hydroxyl radical generation in sodium percarbonate-based Fenton reaction enables efficient degradation of chlorinated hydrocarbons.

Journal of hazardous materials·2026
Same author

From silenced shock to strategic resilience: a longitudinal qualitative study of nurse residents' trajectory in coping with patient verbal abuse.

Frontiers in psychology·2026
Same author

In Situ Oxygen Shuttling within a Bilayer Electrified Membrane Enables Aeration-Free Electro-Fenton Water Purification.

ACS nano·2026
Same author

Evaluation of a Digital Intervention for Monitoring and Improving Medication Adherence Among Real-World e-Consumers of HIV Preexposure Prophylaxis in China: Protocol for a Randomized Controlled Trial.

JMIR research protocols·2026
Same author

Resilient interpersonal pathways from loneliness to suicidal ideation among Chinese transgender women during global health crises.

General psychiatry·2026

相关实验视频

Updated: Sep 18, 2025

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

2.5K

预防和控制艾滋病毒的生物医学干预措施:超越疫苗接种.

Yu Liao1,2, Ziyu Wen1,2, Minjuan Shi1,2

  • 1School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen 518107, China.

Viruses
|June 27, 2025
PubMed
概括

创新的生物医学干预措施对于控制人类免疫缺陷病毒 (HIV) 流行病至关重要. 本综述探讨了开发超越疫苗的新艾滋病毒预防和治疗策略的挑战和进展.

关键词:
2030年目标目标2030年的目标艾滋病流行病 艾滋病流行病艾滋病病毒 艾滋病病毒 艾滋病病毒生物医学干预措施预防 预防 预防

更多相关视频

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

18.7K
Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays
13:58

Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays

Published on: September 26, 2011

31.8K

相关实验视频

Last Updated: Sep 18, 2025

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

2.5K
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

18.7K
Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays
13:58

Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays

Published on: September 26, 2011

31.8K

科学领域:

  • 传染性疾病 传染性疾病
  • 疫苗学 疫苗学 疫苗学
  • 公共卫生 公共卫生

背景情况:

  • 全球人类免疫缺陷病毒 (HIV) 疫情由于缺乏治疗方法或广泛有效的疫苗而持续存在.
  • 生物医学干预是控制艾滋病毒传播和感染的关键.
  • 有效的艾滋病毒疫苗仍然是一个关键的,但尚未可用的工具.

研究的目的:

  • 讨论针对艾滋病毒的生物医学干预创新的挑战.
  • 总结当前的情况和艾滋病生物医学干预的最新进展.
  • 确定预防和控制艾滋病毒的新策略,帮助实现2030年艾滋病流行病目标.

主要方法:

  • 文献综述和对现有关于HIV生物医学干预的研究进行综合.
  • 分析艾滋病毒疫苗和药物开发中的技术障碍.
  • 探索艾滋病毒预防的替代和创新方法.

主要成果:

  • 尽管面临挑战,但各种创新的生物医学干预措施正在出现,用于预防和控制艾滋病毒.
  • 进展集中在拦截艾滋病毒的获取和传播途径上.
  • 开发管道包括超越传统疫苗接种的战略.

结论:

  • 克服创新挑战对于推动艾滋病毒生物医学干预至关重要.
  • 需要采用多方面的方法,结合现有和新的战略.
  • 继续研究开箱式解决方案至关重要,以在2030年前结束艾滋病流行.